- Home
- ANTX vs MNDO Comparison
ANTX vs MNDO Comparison
Compare ANTX & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- MNDO
- Stock Information
- Founded
- ANTX 2017
- MNDO 1995
- Country
- ANTX United States
- MNDO Israel
- Employees
- ANTX N/A
- MNDO N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- MNDO EDP Services
- Sector
- ANTX Health Care
- MNDO Technology
- Exchange
- ANTX Nasdaq
- MNDO Nasdaq
- Market Cap
- ANTX 40.0M
- MNDO 39.9M
- IPO Year
- ANTX 2022
- MNDO 2000
- Fundamental
- Price
- ANTX $1.44
- MNDO $1.98
- Analyst Decision
- ANTX Hold
- MNDO
- Analyst Count
- ANTX 5
- MNDO 0
- Target Price
- ANTX $3.50
- MNDO N/A
- AVG Volume (30 Days)
- ANTX 298.6K
- MNDO 23.7K
- Earning Date
- ANTX 11-13-2024
- MNDO 11-05-2024
- Dividend Yield
- ANTX N/A
- MNDO 12.18%
- EPS Growth
- ANTX N/A
- MNDO N/A
- EPS
- ANTX N/A
- MNDO 0.23
- Revenue
- ANTX N/A
- MNDO $21,856,000.00
- Revenue This Year
- ANTX N/A
- MNDO N/A
- Revenue Next Year
- ANTX N/A
- MNDO N/A
- P/E Ratio
- ANTX N/A
- MNDO $8.63
- Revenue Growth
- ANTX N/A
- MNDO 2.27
- 52 Week Low
- ANTX $0.87
- MNDO $1.70
- 52 Week High
- ANTX $22.22
- MNDO $2.28
- Technical
- Relative Strength Index (RSI)
- ANTX 56.85
- MNDO 47.79
- Support Level
- ANTX $1.23
- MNDO $1.94
- Resistance Level
- ANTX $1.43
- MNDO $2.02
- Average True Range (ATR)
- ANTX 0.09
- MNDO 0.04
- MACD
- ANTX -0.01
- MNDO -0.00
- Stochastic Oscillator
- ANTX 58.33
- MNDO 35.00
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets and implements real-time and off-line convergent billing and customer care software solutions. The company derives revenue from sale of software products and services in two operating segments namely Billing and Related Services, which derives key revenue and Messaging. The Company has three product lines: Product line A- billing and customer care solutions for service providers; Product line B - call accounting and call management solutions for enterprises; and Product line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in The Americas, Europe, Asia Pacific and Africa and Israel. It earns maximum revenue from Europe.